Filter Results :

Your search for Lymphoma returned 101 reports

Sort by


Global Lymphoma Partnering 2010 to 2017

01 Oct 2017  |  Published by:  CurrentPartnering
The Global Lymphoma Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals lis...

$ 1,495.00

Read More

Global Non-Hodgkin Lymphoma Partnering 2010 to 2017

01 Oct 2017  |  Published by:  CurrentPartnering
The Global Non-Hodgkin Lymphoma Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • Trends in partnering deals • Top deals by value ...

$ 1,495.00

Read More

The Leukemia & Lymphoma Society Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

14 Sep 2017  |  Published by:  GlobalData
SummaryThe Leukemia & Lymphoma Society Inc (LLS) is a healthcare center that offers blood cancer researches and funds raising services. The center's services include patient services, health education, policy advocacy, funds raising and medical research funding. It offers treatments for the diseases...

$ 250.00

Read More

Follicular Lymphoma Global Clinical Trials Review, H2, 2017

23 Aug 2017  |  Published by:  GlobalData
Summary"Follicular Lymphoma Global Clinical Trials Review, H2, 2017" provides an overview of Follicular Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Follicular Lymphoma. Report includes an overview of trial numbers and their average enrollm...

$ 2,500.00

Read More

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2017

16 Aug 2017  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2017, provides an overview of the Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology) pipeline landscape.Hodgkin disease is a cancer of the ly...

$ 2,000.00

Read More

Anaplastic Lymphoma Kinase (ALK) Inhibitor - Pipeline Insights, 2017

01 Aug 2017  |  Published by:  DelveInsight
DelveInsight’s, “Anaplastic Lymphoma Kinase (ALK) Inhibitor-Mechanism of action Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Anaplastic Lymphoma Kinase (ALK) Inhibitor. The report provides a complete understanding of the pipeline ...

$ 1,250.00

Read More

Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H2, 2017

26 Jul 2017  |  Published by:  GlobalData
Summary"Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H2, 2017" provides an overview of Diffuse Large B-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Diffuse Large B-Cell Lymphoma. Report includes an overview of trial num...

$ 2,500.00

Read More

Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H2, 2017

19 Jul 2017  |  Published by:  GlobalData
Summary"Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H2, 2017" provides an overview of Cutaneous B-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Cutaneous B-Cell Lymphoma. Report includes an overview of trial numbers and the...

$ 2,500.00

Read More

Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H2, 2017

19 Jul 2017  |  Published by:  GlobalData
Summary"Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H2, 2017" provides an overview of Cutaneous T-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Cutaneous T-Cell Lymphoma. Report includes an overview of trial numbers and the...

$ 2,500.00

Read More

Peripheral T-Cell Lymphoma - Competitive Landscape, Market Insights, Epidemiology and Market Forecast - 2023

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight’s ‘Peripheral T-Cell Lymphoma (PTCL) - Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2025’ report provides provides the comprehensive insights on the competitive landscape and market of Peripheral T-Cell Lymphoma (PTCL).The report covers an overview of the Per...

$ 6,950.00

Read More

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Insight, 2017

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight’s, “ Anaplastic Large Cell Lymphoma (ALCL) -Pipeline Insights, 2017”, report provides comprehensive insights about pipeline drugs across this Anaplastic Large Cell Lymphoma (ALCL). The key objective of the report is to establish the understanding for all the pipeline drugs that are unde...

$ 1,250.00

Read More

B-Cell Lymphomas - Pipeline Insight, 2017

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight’s, “ B-Cell Lymphomas -Pipeline Insights, 2017”, report provides comprehensive insights about pipeline drugs across this B-Cell Lymphomas. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across B-Cell Lymphomas. T...

$ 2,000.00

Read More

B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2017

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight’s, “ B-Cell Non-Hodgkin Lymphoma -Pipeline Insights, 2017”, report provides comprehensive insights about pipeline drugs across this B-Cell Non-Hodgkin Lymphoma. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research acro...

$ 1,500.00

Read More

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Insights, 2017

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight’s, “Peripheral T-Cell Lymphoma (PTCL)-Pipeline Insights, 2017”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Peripheral T-Cell Lymphoma (PTCL...

$ 1,250.00

Read More

Peripheral T-Cell Lymphomas (PTCL) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight’s, Peripheral T-Cell Lymphomas (PTCL) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017” report provides comprehensive insights about marketed and Phase III products for the Peripheral T-Cell Lymphomas (PTCL). The report includes information of marketed products i...

$ 2,250.00

Read More
Total 101 records.